HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay

References

• Cardell K, Akerlind B, Sallberg M, et al. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis. 2008;198:299–304.
   PubMed Web of Science ®Google Scholar
• Mishra D, Mishra PK, Dabadghao S, et al. Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomed: Nanotechnol Biol Med. 2010;6:110–118.
   PubMed Web of Science ®Google Scholar
• Kristina Cardell AFBN. Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise. Scand J Infect Dis. 1999;31:197–200.
   PubMedGoogle Scholar
• Filippelli M, Lionetti E, Gennaro A, et al. Hepatitis B vaccine by intradermal route in non responder patients: an update. World J Gastroenterol. 2014;20:10383–10394.
   PubMed Web of Science ®Google Scholar
• Mehrabi M, Dounighi NM, Rezayat SM, et al. Novel approach to improve vaccine immunogenicity: mannosylated chitosan nanoparticles loaded with recombinant hepatitis B antigen as a targeted vaccine delivery system. J Drug Deliv Sci Technol. 2018;44:19–26.
   Web of Science ®Google Scholar
• Keler T, Ramakrishna V, Fanger MW. Mannose receptor-targeted vaccines. Expert Opin Biol Ther. 2004;4:1953–1962.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, Thalhammer T, Tzakos AG, et al. Targeting antigens to dendritic cell receptors for vaccine development. J Drug Deliv. 2013;2013:869718.
   PubMedGoogle Scholar
• Apostolopoulos V, Pietersz GA, Gordon S, et al. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway. Eur J Immunol. 2000;30:1714–1723.
   PubMed Web of Science ®Google Scholar
• Tan MC, Mommaas AM, Drijfhout JW, et al. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol. 1997;27:2426–2435.
   PubMed Web of Science ®Google Scholar
• Alireza H, Amin Z, Mahboubeh E, et al. Targeting Pattern Recognition Receptors (PRRs) in nano- adjuvants: current perspectives. Curr Bionanotechnol. 2016;2:47–59.
   Google Scholar
• Hamdy S, Haddadi A, Shayeganpour A, et al. Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles. Pharm Res. 2011;28:2288–2301.
   PubMed Web of Science ®Google Scholar
• Wang T, Zou M, Jiang H, et al. Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant. Eur J Pharm Sci: Off J Eur Federation Pharm Sci. 2011;44:653–659.
   PubMed Web of Science ®Google Scholar
• Chen YS, Hung YC, Lin WH, et al. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology. 2010;21:195101.
   PubMed Web of Science ®Google Scholar
• Niut Y, Popatt A, Yu M, et al. Recent advances in the rational design of silica-based nanoparticles for gene therapy. Ther Deliv. 2012;3:1217–1237.
   PubMedGoogle Scholar
• Zhao L, Seth A, Wibowo N, et al. Nanoparticle vaccines. Vaccine. 2014;32:327–337.
   PubMed Web of Science ®Google Scholar
• Al-Rhman RMA. Impact of silver nanoparticles on immune responses as vaccine against activated Staphylococcus aureus bacteria. Int J Sci Res. 2017;6(9):280–284.
   Google Scholar
• Scherer F, Anton M, Schillinger U, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002;9:102–109.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao X, Cheng Y, et al. Iron oxide nanoparticles-based vaccine delivery for cancer treatment. Mol Pharm. 2018;15:1791–1799.
   PubMed Web of Science ®Google Scholar
• Hee Kim E, Lee H, Kook Kwak B, et al. Synthesis of ferroluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J Magn Magn Mater. 2005;289:328–330.
   Web of Science ®Google Scholar
• Rosengart AJ, Kaminski MD, Chen H, et al. Magnetizable implants and functionalized magnetic carriers: a novel approach for noninvasive yet targeted drug delivery. J Magn Magn Mater. 2005;293:633–638.
   Web of Science ®Google Scholar
• Yanase M, Shinkai M, Honda H, et al. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res: Gann. 1998;89:775–782.
   PubMedGoogle Scholar
• Bohara RA, Pawar SH. Innovative developments in bacterial detection with magnetic nanoparticles. Appl Biochem Biotechnol. 2015;176:1044–1058.
   PubMed Web of Science ®Google Scholar
• Zeng L, Luo K, Gong Y. Preparation and characterization of dendritic composite magnetic particles as a novel enzyme immobilization carrier. J Mol Catal B: Enzymatic. 2006;38:24–30.
   Google Scholar
• Tu J, Du G, Reza Nejadnik M, et al. Mesoporous silica nanoparticle-coated microneedle arrays for intradermal antigen delivery. Pharm Res. 2017;34:1693–1706.
   PubMed Web of Science ®Google Scholar
• Andrade Â, Ferreira R, Fabris J, et al. Coating nanomagnetic particles for biomedical applications. Biomed Eng-Front Challenges: InTech. 2011;61:69–90.
   Google Scholar
• Bahrami K, Sheikh Arabi M. Copper immobilized ferromagnetic nanoparticle triazine dendrimer (FMNP@TD–Cu(ii))-catalyzed regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles. New J Chem. 2016;40:3447–3455.
   Web of Science ®Google Scholar
• Yang D, Hu J, Fu S. Controlled synthesis of magnetite − silica nanocomposites via a seeded sol − gel approach. J Phys Chem C. 2009;113:7646–7651.
   Web of Science ®Google Scholar
• Khalafi-Nezhad A, Nourisefat M, Panahi F. l-Cysteine functionalized magnetic nanoparticles (LCMNP): a novel magnetically separable organocatalyst for one-pot synthesis of 2-amino-4H-chromene-3-carbonitriles in water. Org Biomol Chem. 2015;13:7772–7779.
   PubMed Web of Science ®Google Scholar
• Ghotbi Z, Haddadi A, Hamdy S, et al. Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles. J Drug Target. 2011;19:281–292.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Prashant CK, Bhat M, Srivastava SK, et al. Fabrication of nanoadjuvant with poly-epsilon-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity. Int J Nanomedicine. 2014;9:937–950.
   PubMed Web of Science ®Google Scholar
• Carrillo-Conde B, Song EH, Chavez-Santoscoy A, et al. Mannose-functionalized “pathogen-like” polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. Mol Pharm. 2011;8:1877–1886.
   PubMed Web of Science ®Google Scholar
• Masuko T, Minami A, Iwasaki N, et al. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem. 2005;339:69–72.
   PubMed Web of Science ®Google Scholar
• Shukla S, Jadaun A, Arora V, et al. In vitro toxicity assessment of chitosan oligosaccharide coated iron oxide nanoparticles. Toxicol Rep. 2015;2:27–39.
   PubMed Web of Science ®Google Scholar
• Hardy E, Martínez E, Diago D, et al. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. J Biotechnol. 2000;77:157–167.
   PubMed Web of Science ®Google Scholar
• Qadis AQ, Goya S, Yatsu M, et al. Effects of a bacteria-based probiotic on subpopulations of peripheral leukocytes and their cytokine mRNA expression in calves. J Vet Med Sci. 2014;76:189–195.
   PubMed Web of Science ®Google Scholar
• Gonzalez DD, Rimondi A, Aguirreburualde MP, et al. Quantitation of cytokine gene expression by real time PCR in bovine milk and colostrum cells from cows immunized with a bovine rotavirus VP6 experimental vaccine. Res Vet Sci. 2013;95:703–708.
   PubMed Web of Science ®Google Scholar
• Wickert L, Steinkrüger S, Abiaka M, et al. Quantitative monitoring of the mRNA expression pattern of the TGF-β-isoforms (β1, β2, β3) during transdifferentiation of hepatic stellate cells using a newly developed real-time SYBR Green PCR. Biochem Biophys Res Commun. 2002;295:330–335.
   PubMed Web of Science ®Google Scholar
• Fard NN, Noorbazargan H, Mirzaie A, et al. Biogenic synthesis of AgNPs using Artemisia oliveriana extract and their biological activities for an effective treatment of lung cancer. Artif Cells Nanomed Biotechnol. 2018;27:1–12.
   Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45–e4e.
   PubMed Web of Science ®Google Scholar
• Solaro R, Chiellini F, Battisti A. Targeted delivery of protein drugs by nanocarriers. Materials. 2010;3:1928–1980.
   Web of Science ®Google Scholar
• Peng XH, Qian X, Mao H, et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed. 2008;3:311–321.
   PubMed Web of Science ®Google Scholar
• Nahar M, Jain NK. Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles. Pharm Res. 2009;26:2588–2598.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S. DLS and zeta potential – what they are and what they are not? J Control Release. 2016;235:337–351.
   PubMed Web of Science ®Google Scholar
• Agarwal M, Kumar Agarwal M, Shrivastav N, et al. Preparation of chitosan nanoparticles and their in-vitro characterization. Int J Life Sci Sci Res. 2018;4:1713–1720.
   Google Scholar
• Cole MA, Thissen H, Losic D, et al. A new approach to the immobilisation of poly(ethylene oxide) for the reduction of non-specific protein adsorption on conductive substrates. Surf Sci. 2007;601:1716–1725.
   Web of Science ®Google Scholar
• Cuiling R, Jinhua L, Xingguo C, et al. Preparation and properties of a new multifunctional material composed of superparamagnetic core and rhodamine B doped silica shell. Nanotechnology. 2007;18:345604.
   Web of Science ®Google Scholar
• Chen L, Xu Z, Dai H, et al. Facile synthesis and magnetic properties of monodisperse Fe3O4/silica nanocomposite microspheres with embedded structures via a direct solution-based route. J Alloys Compounds. 2010;497:221–227.
   Web of Science ®Google Scholar
• Ma D, Guan J, Dénommée S, et al. Multifunctional nano-architecture for biomedical applications. Chem Mater. 2006;18:1920–1927.
   Web of Science ®Google Scholar
• Nigam S, Barick KC, Bahadur D. Development of citrate-stabilized Fe3O4 nanoparticles: conjugation and release of doxorubicin for therapeutic applications. J Magn Magn Mater. 2011;323:237–243.
   Web of Science ®Google Scholar
• Häfeli UO, Pauer GJ. In vitro and in vivo toxicity of magnetic microspheres. J Magn Magn Mater. 1999;194:76–82.
   Web of Science ®Google Scholar
• Zhao Y, Zhao X, Cheng Y, et al. Iron oxide nanoparticles-based vaccine delivery for cancer treatment. Mol Pharm. 2018;15(5):1791–1799.
   PubMed Web of Science ®Google Scholar
• Prego C, Paolicelli P, Díaz B, et al. Chitosan-based nanoparticles for improving immunization against hepatitis B infection. Vaccine. 2010;28:2607–2614.
   PubMed Web of Science ®Google Scholar
• Apostolopoulos V, McKenzie I. Role of the mannose receptor in the immune response. Curr Mol Med. 2001;1:469–474.
   PubMedGoogle Scholar
• Irache JM, Salman HH, Gamazo C, et al. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv. 2008;5:703–724.
   PubMed Web of Science ®Google Scholar
• Boscardin SB, Hafalla JC, Masilamani RF, et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J Exp Med. 2006;203:599–606.
   PubMed Web of Science ®Google Scholar
• Xiang SD, Wilson K, Day S, et al. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods. 2013;60:232–241.
   PubMed Web of Science ®Google Scholar
• Lepenies B, Lee J, Sonkaria S. Targeting C-type lectin receptors with multivalent carbohydrate ligands. Adv Drug Deliv Rev. 2013;65:1271–1281.
   PubMed Web of Science ®Google Scholar
• Agnes M, Tan A, Jordens R, et al. Strongly increased efficiency of altered peptide ligands by mannosylation. Int Immunol. 1998;10:1299–1304.
   PubMed Web of Science ®Google Scholar
• Yeeprae W, Kawakami S, Yamashita F, et al. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release. 2006;114:193–201.
   PubMed Web of Science ®Google Scholar